Does insurance cover ZILRETTA?
The majority of private health insurance plans also cover ZILRETTA. Set personal goals – Before seeing a doctor, set short- and long-term goals for managing your osteoarthritis knee pain. These can help you both decide on a treatment approach that could help you reach your goals.
Is there a generic for ZILRETTA?
(Triamcinolone Acetonide) Zilretta is only available as a brand-name drug. There is currently no generic alternative.
Does ZILRETTA require prior authorization?
Prior authorization is recommended for medical benefit coverage of Zilretta. Coverage is recommended for those who meet the conditions of coverage in the Criteria, Dosing, Initial/Extended Approval, Duration of Therapy, and Labs/Diagnostics for the diagnosis provided.
How many times can you get ZILRETTA injections?
Single and repeat administrations (one injection every three months for a total of three injections) of Zilretta in non-arthritic knee joints of healthy dogs have been studied at ~1.9 times the maximum recommended human dose (MRHD) of 32 mg (based on estimated drug concentrations within the knee joints).
Does ZILRETTA raise blood pressure?
Many people using this medication do not have serious side effects. This medication may raise your blood pressure. Check your blood pressure regularly and tell your doctor if the results are high. This medication may make your blood sugar rise, which can cause or worsen diabetes.
How long does it take for ZILRETTA injection to work?
In the main clinical trial, ZILRETTA significantly reduced knee pain for 3 months. What's more, about 70% of the people had zero to mild knee pain 3 months after treatment.
How often does medicare pay for Zilretta?
Coverage will be provided for one dose per knee and may NOT be renewed. Coverage cannot be renewed.
How do you administer Zilretta?
Zilretta (triamcinolone acetonide extended-release injectable suspension) is administered as an intra-articular injection into the knee joint.
What is the CPT code for Zilretta?
Triamcinolone Acetonide Extended-Release Injectable Suspension, for Intra-Articular Use (Zilretta) HCPCS Code J3490: Billing Guidelines.
What should I do after ZILRETTA injection?
Call your doctor if you have a reaction at the injection site or experience any side effects. Stay active. You can help control stiffness and pain if you keep your knee in motion. Now that you've had your treatment, pay attention to how ZILRETTA works for you.
Is ZILRETTA injection a steroid?
What Is Zilretta? Zilretta (triamcinolone acetonide extended-release injectable suspension) is an extended-release synthetic corticosteroid indicated as an intra-articular injection for the management of osteoarthritis pain of the knee.
How long do ZILRETTA injections last?
While a traditional cortisone shot offers pain relief for a few weeks, the makers of Zilretta say it relieves pain for up to 3 months. This extended pain-relieving power is especially helpful considering that steroid injections can only be given so often—and so many times total—to avoid the risk for soft tissue damage.
What is the new injection for knee pain?
Hyaluronic acid gel injections (viscosupplementation) Hyaluronic acid is a natural lubricant and shock absorber inside of the joints. But the shocks wear out over time. Viscosupplementation injects hyaluronic acid gel into the joint to replace what has been lost. Examples include Hyalgan, Synvisc, and Euflexxa.
Is ZILRETTA a cortisone?
ZILRETTA® (triamcinolone acetonide extended-release injectable suspension) is an extended-release corticosteroid approved to manage osteoarthritis knee pain.
Does ZILRETTA raise blood sugar?
Flexion Therapeutics, Inc. recently released data on its investigational sustained release steroid—Zilretta—indicating that for patients with knee osteoarthritis (OA) and Type 2 diabetes, Zilretta may avoid the rise in blood glucose seen with an immediate-release corticosteroid.
Who manufactures ZILRETTA?
Production lines are rolling at a Thermo Fisher Scientific Inc. facility in the U.K., which began manufacture of Flexion Therapeutics Inc.'s newly approved osteoarthritis drug Zilretta last week.